As of 2025-10-19, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (24.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.49 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -480.1%.
The range of the Relative Valuation is (19.80) - (28.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 15.8x | 13.7x |
| Forward P/E multiples | 10.9x - 17.4x | 13.6x |
| Fair Price | (19.80) - (28.59) | (24.67) |
| Upside | -405.2% - -540.5% | -480.1% |
| Date | P/E |
| 2025-10-16 | -3.60 |
| 2025-10-15 | -3.66 |
| 2025-10-14 | -3.34 |
| 2025-10-13 | -3.47 |
| 2025-10-10 | -3.60 |
| 2025-10-09 | -3.75 |
| 2025-10-08 | -3.38 |
| 2025-10-07 | -3.23 |
| 2025-10-06 | -3.09 |
| 2025-10-03 | -3.03 |
| 2025-10-02 | -2.89 |
| 2025-10-01 | -2.94 |
| 2025-09-30 | -2.89 |
| 2025-09-29 | -2.87 |
| 2025-09-26 | -2.86 |
| 2025-09-25 | -2.42 |
| 2025-09-24 | -2.50 |
| 2025-09-23 | -2.46 |
| 2025-09-22 | -2.51 |
| 2025-09-19 | -2.58 |
| 2025-09-18 | -2.52 |
| 2025-09-17 | -2.26 |
| 2025-09-16 | -2.29 |
| 2025-09-15 | -2.25 |
| 2025-09-12 | -2.21 |
| 2025-09-11 | -2.28 |
| 2025-09-10 | -2.25 |
| 2025-09-09 | -2.25 |
| 2025-09-08 | -2.25 |
| 2025-09-05 | -2.28 |
| 2025-09-04 | -2.21 |
| 2025-09-03 | -2.27 |
| 2025-09-02 | -2.03 |
| 2025-08-29 | -1.99 |
| 2025-08-28 | -2.04 |
| 2025-08-27 | -1.98 |
| 2025-08-26 | -1.96 |
| 2025-08-25 | -1.94 |
| 2025-08-22 | -2.04 |
| 2025-08-21 | -1.89 |
| 2025-08-20 | -1.88 |
| 2025-08-19 | -1.88 |
| 2025-08-18 | -1.92 |
| 2025-08-15 | -1.96 |
| 2025-08-14 | -1.88 |
| 2025-08-13 | -1.89 |
| 2025-08-12 | -1.85 |
| 2025-08-11 | -1.80 |
| 2025-08-08 | -1.78 |
| 2025-08-07 | -1.93 |